C
Cipla Ltd
Pharmaceuticals
LARGECAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 30.21 | 49.81 |
| PB Ratio | 4.65 | 6.38 |
| Dividend Yield | 0.84% | 0.53% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
C
Cipla Ltd
Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious disea...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions